In this session, we will review the common entities, both benign and malignant, that arise in the kidney, testis, bladder, and prostate. The various histologic features will be identified and confirmatory immunohistochemical panels will be discussed. Special attention will be given to recent changes found in the 2022 WHO Classification of Tumours of the Urinary System and Male Genital Organs, as well as newer entities that have entered the GU Pathology realm.
At the end of the sessions, participants will be able to:
- Identify the common entities of the various genitourinary sites.
- Distinguish between common histologic pitfalls.
- Select appropriate immunohistochemical markers in the workup of genitourinary entities.
- Describe some of the updates in the 2022 WHO Classification.
- Reflect on some newly described lesions of the GU tract.
Target Audience: Faculty, Residents
CanMEDS Roles: Medical Expert (the integrating role), Scholar